Bacao, Almera C.
HRN: 20-52-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2023
CEFUROXIME 500MG (TAB)
09/24/2023
10/01/2023
PO
500 Mg Tab
BID
S/P NSVD (In-Transit Delivery)
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes